These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 21048668)

  • 41. β-1,3-glucanase disrupts biofilm formation and increases antifungal susceptibility of Candida albicans DAY185.
    Tan Y; Ma S; Leonhard M; Moser D; Schneider-Stickler B
    Int J Biol Macromol; 2018 Mar; 108():942-946. PubMed ID: 29104052
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro activity of xanthorrhizol isolated from the rhizome of Javanese turmeric (Curcuma xanthorrhiza Roxb.) against Candida albicans biofilms.
    Rukayadi Y; Hwang JK
    Phytother Res; 2013 Jul; 27(7):1061-6. PubMed ID: 22969012
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Yeasts isolated from nosocomial urinary infections: antifungal susceptibility and biofilm production.
    de Freitas AR; Baeza LC; Faria MG; Dota KF; Godoy Martínez P; Svidzinski TI
    Rev Iberoam Micol; 2014; 31(2):104-8. PubMed ID: 23810785
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sustained Nitric Oxide-Releasing Nanoparticles Induce Cell Death in Candida albicans Yeast and Hyphal Cells, Preventing Biofilm Formation In Vitro and in a Rodent Central Venous Catheter Model.
    Ahmadi MS; Lee HH; Sanchez DA; Friedman AJ; Tar MT; Davies KP; Nosanchuk JD; Martinez LR
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2185-94. PubMed ID: 26810653
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biofilm-forming capacity of blood-borne Candida albicans strains and effects of antifungal agents.
    Turan H; Demirbilek M
    Rev Argent Microbiol; 2018; 50(1):62-69. PubMed ID: 28988900
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Simple 96-Well Plate-Based Method for Development of Candida Biofilms Under Static Conditions.
    Uppuluri P
    Methods Mol Biol; 2022; 2542():225-231. PubMed ID: 36008668
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-throughput screening of a collection of known pharmacologically active small compounds for identification of Candida albicans biofilm inhibitors.
    Siles SA; Srinivasan A; Pierce CG; Lopez-Ribot JL; Ramasubramanian AK
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3681-7. PubMed ID: 23689719
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protocol for Determination of the Persister Subpopulation in Candida Albicans Biofilms.
    De Brucker K; De Cremer K; Cammue BP; Thevissen K
    Methods Mol Biol; 2016; 1333():67-72. PubMed ID: 26468100
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biofilm inhibition by Cymbopogon citratus and Syzygium aromaticum essential oils in the strains of Candida albicans.
    Khan MS; Ahmad I
    J Ethnopharmacol; 2012 Mar; 140(2):416-23. PubMed ID: 22326355
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thymol inhibits Candida albicans biofilm formation and mature biofilm.
    Braga PC; Culici M; Alfieri M; Dal Sasso M
    Int J Antimicrob Agents; 2008 May; 31(5):472-7. PubMed ID: 18329858
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relative Abundances of Candida albicans and Candida glabrata in
    Olson ML; Jayaraman A; Kao KC
    Appl Environ Microbiol; 2018 Apr; 84(8):. PubMed ID: 29427422
    [No Abstract]   [Full Text] [Related]  

  • 52. Cyclosporine A decreases the fluconazole minimum inhibitory concentration of Candida albicans clinical isolates but not biofilm formation and cell growth.
    Wibawa T; Nurrokhman ; Baly I; Daeli PR; Kartasasmita G; Wijayanti N
    Trop Biomed; 2015 Mar; 32(1):176-82. PubMed ID: 25801268
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro efficacy of eugenol in inhibiting single and mixed-biofilms of drug-resistant strains of Candida albicans and Streptococcus mutans.
    Jafri H; Khan MSA; Ahmad I
    Phytomedicine; 2019 Feb; 54():206-213. PubMed ID: 30668370
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characteristics of Candida albicans biofilms grown in a synthetic urine medium.
    Uppuluri P; Dinakaran H; Thomas DP; Chaturvedi AK; Lopez-Ribot JL
    J Clin Microbiol; 2009 Dec; 47(12):4078-83. PubMed ID: 19794044
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.
    Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ
    Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug susceptibility of matrix-encapsulated Candida albicans nano-biofilms.
    Srinivasan A; Gupta CM; Agrawal CM; Leung KP; Lopez-Ribot JL; Ramasubramanian AK
    Biotechnol Bioeng; 2014 Feb; 111(2):418-24. PubMed ID: 24114441
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In Vitro Models for Candida Biofilm Development.
    Krom BP; Willems HM
    Methods Mol Biol; 2016; 1356():95-105. PubMed ID: 26519068
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Polymer multilayers loaded with antifungal β-peptides kill planktonic Candida albicans and reduce formation of fungal biofilms on the surfaces of flexible catheter tubes.
    Raman N; Lee MR; Palecek SP; Lynn DM
    J Control Release; 2014 Oct; 191():54-62. PubMed ID: 24862322
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Miltefosine is effective against Candida albicans and Fusarium oxysporum nail biofilms in vitro.
    Machado Vila TV; Sousa Quintanilha N; Rozental S
    J Med Microbiol; 2015 Nov; 64(11):1436-1449. PubMed ID: 26404553
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The European Confederation of Medical Mycology (ECMM) survey of candidaemia in Italy: in vitro susceptibility of 375 Candida albicans isolates and biofilm production.
    Tortorano AM; Prigitano A; Biraghi E; Viviani MA;
    J Antimicrob Chemother; 2005 Oct; 56(4):777-9. PubMed ID: 16144871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.